ScholarLens Back to search
2004•Circulation JournalOpen access

Successful Treatment of Primary Cardiac Lymphoma With Monoclonal CD20 Antibody (Rituximab)

Yukinori Nakagawa, Uichi Ikeda, Masahiro Hirose, Satoshi Ubukata, Takaaki Katsuki, Yuichiro Kaminishi, Tsutomu Saito, Mitsugu Hironaka, Tohru Izumi, Kazuyuki Shimada

Open full text 36 citations

Abstract

Primary cardiac malignant lymphoma is extremely rare and almost all patients die within weeks. Monoclonal CD20 antibody (rituximab) was administered to a patient with primary cardiac B-cell non-Hodgkin's lymphoma expressing a CD20 molecule. The results suggest that rituximab may be a safe and effective new therapy for primary cardiac B-cell lymphoma.

Open-access reader

About this research paper

What this paper is about

Primary cardiac malignant lymphoma is extremely rare and almost all patients die within weeks. Monoclonal CD20 antibody (rituximab) was administered to a patient with primary cardiac B-cell non-Hodgkin's lymphoma expressing a CD20 molecule. The results suggest that rituximab may be a safe and effective new therapy for primary cardiac B-cell lymphoma.

Why it matters

OpenAlex reports 36 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Primary cardiac malignant lymphoma is extremely rare and almost all patients die within weeks. Monoclonal CD20 antibody (rituximab) was administered to a patient with primary cardiac B-cell non-Hodgkin's lymphoma expressing a CD20 molecule. The results suggest that rituximab may be a safe and effective new therapy for primary cardiac B-cell lymphoma.

Key concepts: Rituximab, CD20, Lymphoma, Medicine, Monoclonal antibody, Monoclonal, Antibody, Monoclonal antibody therapy

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Successful Treatment of Primary Cardiac Lymphoma With Monoclonal CD20 Antibody (Rituximab) — Research Paper | ScholarLens